Cargando…
Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections
OBJECTIVES: Mortality of patients requiring Intensive Care Unit (ICU) admission for an invasive group A streptococcal (GAS) infection continues being high. In critically ill patients with bacteremic GAS infection we aimed at determining risk factors for mortality. PATIENTS AND METHODS: Retrospective...
Autores principales: | Fernández-Galilea, Adela, Estella, Ángel, García-Garmendia, José Luis, Loza, Ana, Palacios-García, Inmaculada, Sierra-Camerino, Rafael, Seller, Gemma, Rodríguez-Delgado, Marina, Rodriguez-Higueras, Isabel, Garnacho-Montero, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548074/ https://www.ncbi.nlm.nih.gov/pubmed/35796693 http://dx.doi.org/10.37201/req/030.2022 |
Ejemplares similares
-
Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
por: Laho, Delphine, et al.
Publicado: (2021) -
Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis
por: Parks, Tom, et al.
Publicado: (2018) -
1370. Role of Clindamycin Versus Linezolid for Serious Group A Streptococcal Infections
por: Heil, Emily, et al.
Publicado: (2021) -
From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic()
por: Estella, Ángel, et al.
Publicado: (2020) -
Randomized Clinical Trial of Intrapartum Clindamycin Cream for Reduction of Group B Streptococcal
Maternal and Neonatal Colonization
por: Gibbs, R. S., et al.
Publicado: (1996)